Novel indication for myeloid progenitor use: induction of tolerance

Ended Project Grant Awarded Last action

Award ID
R41AI108016
Recipient
Awarding agency
Obligated
$200,787

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Place of performance
San Carlos, CA 94070, USA

Award details come from USAspending.gov.

Quick answers

Who received award R41AI108016?

R41AI108016 was awarded to Cellerant Therapeutics, Inc. by National Institutes of Health (Department of Health and Human Services) on August 1, 2013.

How much is award R41AI108016 worth?

$200,787 has been obligated on R41AI108016.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award